Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 401

Results For "IMI"

4074 News Found

Alembic announces USFDA approval for two drugs
News | May 06, 2021

Alembic announces USFDA approval for two drugs

Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 2% and 0.5% has an estimated market size of US $80 million for twelve months ending December 2020 according to IQVIA


Govt. allocates 16.5 lakh vials of Remdesivir between May 3-9
News | May 06, 2021

Govt. allocates 16.5 lakh vials of Remdesivir between May 3-9

Seven manufacturers of Remdesivir have increased production capacity to 1.03 crore vials per month up from 38 lakh vials per month a month ago


Morepen Laboratories net profit up 189%
News | May 05, 2021

Morepen Laboratories net profit up 189%

R&D Centre will be housed in Baddi and will cater to all business divisions in addition to expansion plans for all its verticals including APls, Formulations and Medical Devices


Natco receives emergency use approval for Baricitinib tablets
News | May 05, 2021

Natco receives emergency use approval for Baricitinib tablets

The company will be requesting a Compulsory License based on emergency use and in light of the grave and serious public health emergency across India due to the Pandemic


Glenmark launches Ryaltris-AZ at affordable price
News | May 04, 2021

Glenmark launches Ryaltris-AZ at affordable price

First company in the world to launch Ryaltris-AZ, as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg


Reliance produces 1000 MTPD medical grade liquid oxygen
News | May 01, 2021

Reliance produces 1000 MTPD medical grade liquid oxygen

This oxygen is being provided free-of-cost to several state governments across the country to bring immediate relief to over 1 lakh patients on a daily basis


Cipla signs agreement with Merck for Molnupiravir
News | April 29, 2021

Cipla signs agreement with Merck for Molnupiravir

Molnupiravir is an investigational oral antiviral drug currently being studied in a Phase 3 trial for the treatment of non-hospitalized patients with confirmed COVID-19


Glenmark’s Ryaltris nasal spray approved in Europe
News | April 27, 2021

Glenmark’s Ryaltris nasal spray approved in Europe

In some countries such as France, Italy, Spain and the Balkan region, Menarini Group will lead the commercialisation effort, as part of an exclusive licensing agreement signed with Glenmark


Vaishali Pharma bags order worth US $270,000 from Afghanistan
News | April 26, 2021

Vaishali Pharma bags order worth US $270,000 from Afghanistan

This achievement enables the company to strengthen its presence in the high growth market of South Asian countries


Ports waive-off all charges for ships carrying oxygen
News | April 26, 2021

Ports waive-off all charges for ships carrying oxygen

Port chairpersons have been asked to personally supervise logistic operations to ensure unhindered movement of such consignments for berthing of such vessel on top priority in the port